India Rejects TB Alliance Patent Bid for BPaL Tuberculosis Treatment, Opening Door to Generic Competition
Why the BPaL TB regimen patent India ruling matters: the Patent Office rejected TB Alliance’s application. What it means and what is unknown.
Why the BPaL TB regimen patent India ruling matters: the Patent Office rejected TB Alliance’s application. What it means and what is unknown.